XML 28 R9.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net income $ 77,480 $ 53,412 $ 58,669
Adjustments to reconcile net income to net cash provided by operating activities:      
Provision (credit) for credit losses 15,712 9,826 15,698
Depreciation and amortization of premises and equipment 7,103 6,878 6,943
Loss on disposal of premises and equipment 2,002 56 (5,059)
Non-cash lease expense (benefit) 0 159 13
Cash flows from operating leases (5,048) (5,073) (5,095)
Amortization of mortgage servicing rights 843 776 705
Net amortization of premium (accretion of discount) on investment securities (1,283) 1,766 3,049
Share-based compensation 2,254 2,072 1,636
Net loss (gain) on sales of investment securities 30 9,934 2,074
Net gain on sales of residential mortgage loans (1,628) (1,257) (721)
Proceeds from sales of loans held for sale 104,432 68,339 39,950
Origination of loans held for sale (98,226) (70,966) (39,902)
Equity in (earnings) losses of unconsolidated entities (106) 21 22
Distributions from unconsolidated entities 941 0 51
Net increase in cash surrender value of bank-owned life insurance (7,452) (6,619) (5,366)
Deferred income tax expense (15,491) 8,771 11,211
Net tax benefit from share-based compensation 270 57 154
Amortization and impairment of intangible assets 0 1,461 39
Net change in other assets and liabilities 15,632 10,906 21,041
Net cash provided by operating activities 97,465 90,519 105,112
Cash flows from investing activities:      
Purchases of investment securities available-for-sale (50,592) (253,580) (47,393)
Proceeds from maturities, prepayments and calls of investment securities available-for-sale 75,459 57,371 60,101
Proceeds from sales of investment securities available-for-sale 1,480 96,562 29,476
Proceeds from maturities, prepayments and calls of investment securities held-to-maturity 40,477 41,690 39,099
Loan payments (originations), net 130,947 131,598 111,012
Purchases of loan portfolios (99,592) (49,443) (19,659)
Proceeds from sales of loans originated for investment 0 9,397 9,629
Purchases of bank-owned life insurance (1,157) (3,008) 0
Proceeds from bank-owned life insurance death benefits 4,109 4,117 2,627
Net purchases of premises, equipment and land (5,162) (15,092) (12,650)
Proceeds from sales of premises, equipment and land 0 0 6,216
Net return of capital from unconsolidated entities 0 0 495
Contributions to unconsolidated entities (9,876) (18,822) (1,645)
Net proceeds from (purchases) redemption of FRB and FHLB stock (18,907) (136) 2,353
Net cash provided by investing activities 67,186 654 179,661
Cash flows from financing activities:      
Net (decrease) increase in deposits (34,247) (203,581) 111,369
Net decrease in FHLB advances and other short-term borrowings 0 0 (5,000)
Proceeds from long-term debt 0 0 50,000
Repayments of long-term debt (80,000) 0 0
Cash dividends paid on common stock (29,356) (28,143) (28,117)
Repurchases of common stock and other related costs (23,336) (945) (2,632)
Net cash (used in) provided by financing activities (166,939) (232,669) 125,620
Net (decrease) increase in cash and cash equivalents (2,288) (141,496) 410,393
Cash and cash equivalents at beginning of year 380,941 522,437 112,044
Cash and cash equivalents at end of year 378,653 380,941 522,437
Cash paid during the year for:      
Interest expense paid 70,295 103,263 58,448
Income taxes (received) paid, net 21,352 (9,213) 7,313
Supplemental non-cash disclosures:      
Lease liabilities arising from obtaining right-of-use lease assets 2,643 5,117 0
Amortization of unrealized losses on investment securities transferred to held-to-maturity at fair value 6,762 7,159 7,440
Other intangible assets received in exchange for Swell common stock $ 0 $ 0 $ 1,500